Fig. 3From: Real-life impacts of olipudase alfa: The experience of patients and families taking an enzyme replacement therapy for acid sphingomyelinase deficiencySurvey reported impact of ASMD on caregivers’ wellbeing before olipudase alfa treatment (n = 10). Percentages cumulatively are higher than 100% as respondents were able to report more than one impactBack to article page